The immune
system of human body recognize some invaders such as bacteria,
viruses, and external chemicals and attacks those to protect the
body. However, sometimes the immune system attacks the healthy cells
of body by considering them as foreign cells. Such a condition is
called autoimmune disease. The autoimmune disease causes abnormal
organ growth and changes in organ function. The genes of an
individual with environmental exposure might be the major reason for
autoimmune disease development. Some of the common autoimmune
diseases among over 80 types of autoimmune diseases are type 1
diabetes, systemic lupus erythematosus, inflammatory bowel disease,
rheumatoid arthritis. The curing therapy for autoimmune diseases is
not yet available only relieving treatments are available for this
diseases. Diagnosis of the autoimmune diseases can be done by the
tests which involves antinuclear antibody test, antibody test,
complete blood counts and some others.
Fill
the form for an exclusive sample of this report :
https://www.coherentmarketinsights.com/insight/request-sample/419
The
growing incidences of autoimmune diseases and government initiatives
to boost the autoimmune disease diagnostics market
According
to American Autoimmune Related Disease Association (AARDA), in 2016,
around 50 million people suffered from autoimmune diseases in the
U.S. with 75% being women. Increasing incidence of autoimmune
diseases, rising public awareness and government initiatives taken to
spend the budget on diagnosis and care services for autoimmune
diseases, are some of the factors which are driving the autoimmune
disease diagnostics market. Many of the organizations and governments
are funding the research and development program for autoimmune
diseases, this will help to launch the new products in the market and
definitely help in the growth of autoimmune disease diagnostics
industry. For instance, the discovery of novel biomarkers, which has
proven to be significant to improve the diagnosis of autoimmune
diseases is also one of the major factor driving the autoimmune
diseases diagnostic market.
Despite of
all the driving factors for the autoimmune disease diagnostics market
there are some restraints which slowing down the market such as, high
rate of false results, slow turnaround time for test results and lack
of experience and education of laboratory personnel in the
diagnostics of certain autoimmune diseases.
Aging
population and technological advancements in diagnosis of rheumatoid
arthritis will be the cause of growth for rheumatoid arthritis
segment
The global
autoimmune disease diagnostic market are segmented on the basis of
disease type, test type, end user and geography
On the
basis of disease type, the autoimmune disease diagnostic market is
segmented into:
-
Systemic Autoimmune Disease diagnostics
-
Rheumatoid Arthritis
-
Ankylosing Spondylitis
-
Systemic Lupus Erythematosus
-
Some Others
-
Localized autoimmune disease diagnostics
-
Multiple Sclerosis
-
Type 1 diabetes
-
Hashimoto’s thyroiditis
-
Idiopathic Thrombocytopenic purpura
The high
patient awareness level and large procedure volumes are the reasons
that localized autoimmune disease diagnostics is dominating the
overall market. Though the initiatives taken by government for
patients suffering from rheumatoid arthritis and systemic lupus
erythematosus will aid in the growth of systemic autoimmune disease
diagnostics segment.
On the
basis of test type, the global autoimmune disease diagnostic market
is segmented into:
-
Antinuclear Antibody Tests
-
Autoantibody Tests
-
Complete Blood Count
-
C-reactive Protein
-
Others
On the
basis of end user, the global autoimmune disease diagnostics market
is segmented into
-
Hospitals
-
Diagnostics Centers
-
Research Laboratories
The
technological advancements in the North America region driving the
autoimmune disease diagnostics market
The
regional segmentation of autoimmune disease diagnostics market by
Coherent Market Insights comprises North America, Europe, Asia
Pacific, Africa and rest of the world. North America is of the
largest revenue contributor in the global autoimmune disease
diagnostics industry. This is mainly attributed to rising incidence
of some of the common autoimmune diseases like rheumatoid arthritis
and type1 diabetes. The increase in funding by government and private
sector, increasing regulatory scenario monitored by World Health
Organization (WHO), and technological advancements are some of the
factors which are driving growth of the autoimmune disease
diagnostics market in the North America region. Asia Pacific is
projected to be a fast emerging region in the global autoimmune
disease diagnostic market.
Request
to view table of content @
https://www.coherentmarketinsights.com/ongoing-insight/toc/419
The
introduction of novel biomarkers in the market will aid in the growth
of autoimmune disease diagnostic market
The key
players operating the autoimmune disease diagnostics market are
Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories,
Euroimmun, Inova Diagnostics, Roche Diagnostics, Siemens Healthcare,
A. Menarini Diagnostics, Adaptive Biotechnologies, AESKU Diagnostics,
and many others. The government agencies of various countries are
increasing their healthcare spending to provide better health care
services, and the introduction of novel biomarkers in the research
area, owing for ample opportunity for the key players, which in-turn
will boost the autoimmune diseases diagnostic market.
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity
No comments:
Post a Comment